등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG UN17-16희귀암

  Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16)

  • 저널 Transl Cancer Res. 2020 May;9(5):3222-3230.
  • 제1저자 변성규, 강명주, 최윤지
  • 교신저자 김승태

• KCSG HN13-01두경부식도암

  Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)

  • 저널 BMC Cancer. 2020 Aug 27;20(1):813
  • 제1저자 이윤규
  • 교신저자 윤환중

• KCSG UN17-16희귀암

  Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer

  • 저널 Mol Clin Oncol . 2017 Jul;7(1):27-31.
  • 제1저자 정기선
  • 교신저자 김승태

• KCSG BR15-10유방암

  Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.

  • 저널 Lancet Oncol. 2019 Dec;20(12):1750-1759
  • 제1저자 박연희
  • 교신저자 박연희

• KCSG PC13-09완화의료

  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy

  • 저널 Oncologist. 2020 Mar;25(3):e502-e511.
  • 제1저자 홍수정
  • 교신저자 김지현

• KCSG LU15-09폐암

  Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations:
  A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

  • 저널 J Clin Oncol. 2020 Feb 10;38(5):488-495
  • 제1저자 조장호
  • 교신저자 안명주

• KCSG GU12-03비뇨기/부인암

  Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma:A Single-Arm, Open-Label, Multicenter, Phase II Study

  • 저널 Cancer Res Treat. 2018 Apr;50(2):488-494
  • 제1저자 정기선
  • 교신저자 임호영

• KCSG CO17-07대장암

  A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer

  • 저널 Cancer Res Treat. 2020 Oct;52(4):1135-1144.
  • 제1저자 김좌훈
  • 교신저자 김태원

• KCSG PC14-17완화의료

  Interference with daily functioning by breakthrough pain in patients with cancer

  • 저널 Support Care Cancer. 2020 Nov;28(11):5177-5183
  • 제1저자 강정훈
  • 교신저자 이경희

• N/A간담췌암

  Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.

  • 저널 Ther Adv Med Oncol. 2019 Aug 23;11:1758835919871126
  • 제1저자 유창훈
  • 교신저자 박준오/류백렬

678910